Gino Noris
National Autonomous University of Mexico
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gino Noris.
Journal of Leukocyte Biology | 1996
Carla Santana; Gino Noris; Bertha Espinoza; Enrique Ortega
Membrane receptors for the Fc portion of immunoglobulin G (IgG) antibodies (FcγRs) are expressed on almost every type of hematopoietic cells, where they mediate a wide variety of effector functions. A high degree of structural heterogeneity exists among FcγRs. The biological significance of such heterogeneity is unknown, since the structural diversity does not appear to be reflected in the binding specificity nor in the effector functions that each distinct receptor is able to mediate. Recent work has emphasized the essential role of protein tyrosine phosphorylation in the initiation of trans‐membrane signaling by these receptors. In this article we review the role of protein tyrosine phosphorylation in signal transduction by the different types of FcγRs in order to assess to what extent the structural heterogeneity of this receptor family is related to different activation pathways utilized by each of its members. J. Leukoc. Biol. 60: 433–440; 1996.
Endocrine | 2001
Luis Beltran-Parrazal; Gino Noris; Carmen Clapp; Gonzalo Martínez de la Escalera
Abstractγ-Aminobutyric acid (GABA) has been implicated in the regulation of reproduction, particularly in the developmental modulation of gonadotropin-releasing hormone (GnRH) secretion. GnRH neurons are innervated by GABA-containing processes, and the administration of GABA stimulates and inhibits GnRH secretion in vivo and in vitro. We have previously shown that GABA can exert both of these actions in sequence, by acting directly on immortalized GnRH neurons. While the stimulation is the result of a GABAA receptor-mediated depolarization of the plasma membrane, the mechanism involved in the delayed inhibition is the subject of the present investigation. GABA (1 nM-10 µM) decreased the intracellular concentration of cyclic adenosine monophosphate (cAMP) in a dose- and time-dependent fashion. This effect was blocked by bicuculline and mimicked by muscimol but not by baclofen. To analyze the effect of GABA on cellular excitability, we used fura-2 loaded GT1-7 cells. Activation of voltage-sensitive calcium channels by high K+-induced depolarization (35 mM) increased [Ca2+]i. GABA (10µM) and muscimol (10 µM) reduced the amplitude of K+-induced [Ca2+]i transients. This inhibition was blocked by forskolin (20µM) or 8-Br-cAMP (1 mM). Altogether, these results show that GABAA receptors mediate a sustained inhibitory effect of GABA on GnRH neurons, and suggest the involvement of the cAMP pathway decreasing cellular excitability.
Journal of Human Genetics | 2016
Rocío Gómez; Luisa Torres-Sánchez; Rafael Camacho-Mejorado; Ana I. Burguete-García; Ruth Argelia Vázquez-Salas; Gabriela Angélica Martínez-Nava; Carla Santana; Gino Noris
A short CAG repeat length in the gene encoding for the androgen receptor (AR) has been associated with prostate cancer (PC) risk and aggressiveness. In Latino men, information on this association is scarce. Hence, the aim of this study was to evaluate this association in Mexican males. Using fragment analysis by capillary electrophoresis, we determined the number of CAG repeats—(CAG)n—in AR gene from 158 incident PC cases and 326 age-matched healthy controls (±5 years), residing in Mexico City, Mexico. According to Gleason scale and age at diagnosis, cases were classified as high (⩾7) and low grade (<7), as well as early onset (<60 years) or late onset PC (⩾60 years). At diagnosis, 78% of cases were classified as high-grade and 26.6% as early onset. Men with sporadic (no family history of PC) and early-onset PC presented shorter CAG repeat length than controls (18.6±2.2 vs 19.5±2.5; P=0.02). Lower number of CAG repeats (CAG)⩽19 were associated with a greater risk for early-onset PC (odds ratio: 2.31; 95% confidence interval: 1.14–4.69). CAG repeat length could increase the risk for sporadic and early-onset PC. The best cutoff point for identifying at-risk subjects was (CAG)19. However, further studies are necessary to replicate our findings in subjects with a family history of PC and also to evaluate the association between CAG repeats length and disease progression.
BioMed Research International | 2014
Marco Antonio Meraz-Ríos; Abraham Majluf-Cruz; Carla Santana; Gino Noris; Rafael Camacho-Mejorado; Leonor C. Acosta-Saavedra; Emma S. Calderón-Aranda; Jesús Hernández-Juárez; Jonathan J. Magaña; Rocío Gómez
Objective. Venous thromboembolism (VTE) is a multifactorial disorder and, worldwide, the most important cause of morbidity and mortality. Genetic factors play a critical role in its aetiology. Microsatellites are the most important source of human genetic variation having more phenotypic effect than many single nucleotide polymorphisms. Hence, we evaluate a possible relationship between VTE and the genetic variants in von Willebrand factor, human alpha fibrinogen, and human thyroid peroxidase microsatellites to identify possible diagnostic markers. Methods. Genotypes were obtained from 177 patients with VTE and 531 nonrelated individuals using validated genotyping methods. The allelic frequencies were compared; Bayesian methods were used to correct population stratification to avoid spurious associations. Results. The vWA-18, TPOX-9, and TPOX-12 alleles were significantly associated with VTE. Moreover, subjects bearing the combination vWA-18/TPOX-12 loci exhibited doubled risk for VTE (95% CI = 1.02–3.64), whereas the combination vWA-18/TPOX-9 showed an OR = 10 (95% CI = 4.93–21.49). Conclusions. The vWA and TPOX microsatellites are good candidate biomarkers in venous thromboembolism diseases and could help to elucidate their origins. Additionally, these polymorphisms could become useful markers for genetic studies of VTE in the Mexican population; however, further studies should be done owing that this data only show preliminary evidence.
Journal of Endocrinology | 1998
Carmen Clapp; F J López-Gómez; Gabriel Nava; Ana M. Corbacho; L Torner; Yazmín Macotela; Zulma Dueñas; Alejandra Ochoa; Gino Noris; E Acosta; E Garay; G. Martínez de la Escalera
Journal of Endocrinology | 2000
Ana M. Corbacho; Yazmín Macotela; Gabriel Nava; L Torner; Z Dueñas; Gino Noris; Miguel A. Morales; G. Martínez de la Escalera; Carmen Clapp
Journal of Biological Chemistry | 2000
Ana M. Corbacho; Gabriel Nava; Jason P. Eiserich; Gino Noris; Yazmín Macotela; Ingrid Struman; Gonzalo Martínez de la Escalera; Bruce A. Freeman; Carmen Clapp
Endocrinology | 1995
Gino Noris; D Hol; Carmen Clapp; G. Martínez de la Escalera
Molecular Biology Reports | 2012
Gino Noris; Carla Santana; Marco Antonio Meraz-Ríos; María de Lourdes Muñoz; Abraham Majluf-Cruz; Jonathan J. Magaña; Julio Granados; Rosa Quezada; María Cristina Revilla; Sergio Martínez-Salas; Salvador Xihuitl; Gonzalo Martínez de la Escalera; Alvaro Díaz-Badillo; Emma S. Calderon-Aranda; Rocío Gómez
Human Biology | 2014
Carla Santana; Gino Noris; Marco Antonio Meraz-Ríos; Jonathan J. Magaña; Emma S. Calderón-Aranda; María de Lourdes Muñoz; Rocío Gómez
Collaboration
Dive into the Gino Noris's collaboration.
Gonzalo Martínez de la Escalera
National Autonomous University of Mexico
View shared research outputs